SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill, Kevin Benedict

News Feed Item

Medbox Executive Interviewed on iCannabisradio.com

WEST HOLLYWOOD, Calif., Dec. 31, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced that an audio interview is available featuring the company's Chief Operations Officer, Vincent Mehdizadeh.

"Being an industry leader means responding to tough questions and educating the public about the many facets of our company," stated Vincent Mehdizadeh, COO at Medbox, Inc. "We thank the team at iCannabis radio for providing the platform for our ongoing ambassadorship of the burgeoning marijuana industry."

The interview can be heard at the following link at 10 minutes and 35 seconds:

http://www.youtube.com/watch?v=Co-PchEeX_U

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Florida, and has their corporate headquarters in West Hollywood, California.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets (Pink Sheets), ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.

SOURCE Medbox, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.